Emivirine

Emivirine is a failed experimental agent for the treatment of HIV. It is a non-nucleoside reverse transcriptase inhibitor.

Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)
Entry/fusion inhibitors
(Discovery & development)
  • gp41 (Enfuvirtide)
  • CCR5 (Maraviroc
  • Vicriviroc†, Cenicriviroc†, PRO 140†)
  • CD4 (Ibalizumab†)
Reverse-transcriptase
inhibitors (RTIs)
Nucleoside &
nucleotide (NRTI)
  • Nucleoside analogues/NARTIs: Abacavir (ABC)°#
  • Emtricitabine (FTC)°#
  • Lamivudine (3TC)°#
  • Didanosine (ddI)#
  • Zidovudine (AZT)#
  • Apricitabine†
  • Stampidine†
  • Elvucitabine†
  • Racivir†
  • Amdoxovir†
  • Stavudine (d4T)#
  • Zalcitabine (ddC)◊
  • Festinavir†
  • Nucleotide analogues/NtRTIs: Tenofovir disoproxil fumarate (TDF)°#
  • Tenofovir alafenamide fumarate (TAF)†
Non-nucleoside (NNRTI)
(Discovery & development)
  • (1st generation) Efavirenz (EFV)°#
  • Nevirapine (NVP)#
  • Loviride◊
  • Delavirdine (DLV)◊

  • (2nd generation) diarylpyrimidines (Etravirine
  • Rilpivirine)
  • Lersivirine†
Integrase inhibitors
  • Raltegravir°
  • Elvitegravir
  • Dolutegravir†
  • Globoidnan A (experimental)
  • MK-2048†
  • BI 224436†
  • GSK744†
Maturation inhibitors
  • Bevirimat†
Protease Inhibitors (PI)
(Discovery and development)
1st generation
  • Fosamprenavir°
  • Lopinavir°#
  • Nelfinavir#
  • Ritonavir#
  • Saquinavir#
  • Amprenavir◊
  • Indinavir◊#
2nd generation
  • Atazanavir°
  • Darunavir°
  • Tipranavir
Combined formulations
  • Lamivudine/zidovudine
  • Emtricitabine/tenofovir/efavirenz
  • Abacavir/lamivudine/zidovudine
  • Tenofovir/emtricitabine
  • Lopinavir/ritonavir
  • Abacavir/lamivudine
  • Emtricitabine/rilpivirine/tenofovir
  • Elvitegravir/cobicistat/emtricitabine/tenofovir
Experimental agents
Uncoating inhibitors
  • TRIM5alpha (gene)
Transcription inhibitors
  • Tat antagonists
Translation inhibitors
  • Trichosanthin
Other
  • Abzyme
  • Calanolide A
  • Ceragenin
  • Cyanovirin-N
  • Diarylpyrimidines
  • Epigallocatechin gallate (EGCG)
  • Foscarnet
  • Griffithsin
  • Hydroxycarbamide
  • Miltefosine
  • Portmanteau inhibitors
  • Seliciclib†
  • Synergistic enhancers
  • Tre recombinase
  • Zinc finger protein transcription factor
  • KP-1461†
  • Cobicistat†
Failed agents
  • Dexelvucitabine
  • Capravirine
  • Emivirine
  • Lodenosine
  • Atevirdine
  • Brecanavir
  • Aplaviroc
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III
°DHHS preferred first-line agent. ◊Formerly or rarely used agent.

M: VIR

virs(prot)/clss

cutn/syst (hppv/hiva, infl/zost/zoon)/epon

drug (dnaa, rnaa, rtva, vacc)